How Sweet It Is: Lilly Surges Above $90 on Diabetes Drug Data

Nothing moves a drug stock like strong clinical trials results. Eli Lilly & Co. (LLY) surged more than 6% after the drug maker released study results showing the diabetes drug Jardiance reduced the change of death for diabetics at high risk of heart complications. This makes Jardiance the first medication shown to lengthen the lives […]